Literature DB >> 16040375

Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users.

Evan Wood1, Kathy Li, Anita Palepu, David C Marsh, Martin T Schechter, Robert S Hogg, Julio S G Montaner, Thomas Kerr.   

Abstract

Vancouver's explosive HIV epidemic among injection drug users (IDUs) has received international attention due to the presence of a large needle exchange program. The role of addiction treatment has not been evaluated in this setting. We evaluated factors associated with use of addiction treatment among a prospective cohort of Vancouver IDUs. Addiction treatment was negatively associated with Aboriginal ethnicity and unstable housing, both of which have been associated with HIV infection in previous studies. These findings demonstrate low levels of addiction treatment among Vancouver IDUs and suggest that programs may need to be targeted towards specific populations with poor access.

Entities:  

Mesh:

Year:  2005        PMID: 16040375     DOI: 10.1081/JA-200042287

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  20 in total

1.  Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.

Authors:  Evan Wood; Mark W Tyndall; Julio S Montaner; Thomas Kerr
Journal:  CMAJ       Date:  2006-11-21       Impact factor: 8.262

2.  Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility.

Authors:  M-J S Milloy; Thomas Kerr; Ruth Zhang; Mark Tyndall; Julio Montaner; Evan Wood
Journal:  J Public Health (Oxf)       Date:  2009-09-23       Impact factor: 2.341

3.  Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?

Authors:  Kenneth Blum; Thomas J H Chen; John Bailey; Abdalla Bowirrat; John Femino; Amanda L C Chen; Thomas Simpatico; Siobhan Morse; John Giordano; Uma Damle; Mallory Kerner; Eric R Braverman; Frank Fornari; B William Downs; Cynthia Rector; Debmayla Barh; Marlene Oscar-Berman
Journal:  Mol Neurobiol       Date:  2011-09-24       Impact factor: 5.590

4.  Methadone use among HIV-positive injection drug users in a Canadian setting.

Authors:  Tyler Pettes; Evan Wood; Silvia Guillemi; Calvin Lai; Julio Montaner; Thomas Kerr
Journal:  J Subst Abuse Treat       Date:  2010-07-03

5.  The impact of engagement in street-based income generation activities on stimulant drug use cessation among people who inject drugs.

Authors:  Lianping Ti; Lindsey Richardson; Kora DeBeck; Paul Nguyen; Julio Montaner; Evan Wood; Thomas Kerr
Journal:  Drug Alcohol Depend       Date:  2014-05-17       Impact factor: 4.492

6.  Need for equity in treatment of substance use among Indigenous people in Canada.

Authors:  Karen A Urbanoski
Journal:  CMAJ       Date:  2017-11-06       Impact factor: 8.262

7.  Coercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, Canada.

Authors:  Andreas Pilarinos; Brittany Barker; Ekaterina Nosova; M-J Milloy; Kanna Hayashi; Evan Wood; Thomas Kerr; Kora DeBeck
Journal:  Addiction       Date:  2019-09-06       Impact factor: 6.526

8.  Access to drug and alcohol treatment among a cohort of street-involved youth.

Authors:  Scott E Hadland; Thomas Kerr; Kathy Li; Julio S Montaner; Evan Wood
Journal:  Drug Alcohol Depend       Date:  2008-12-09       Impact factor: 4.492

Review 9.  The role of safer injection facilities in the response to HIV/AIDS among injection drug users.

Authors:  Thomas Kerr; Jo Kimber; Kora Debeck; Evan Wood
Journal:  Curr HIV/AIDS Rep       Date:  2007-12       Impact factor: 5.071

10.  Harm reduction in hospitals: is it time?

Authors:  Beth S Rachlis; Thomas Kerr; Julio S G Montaner; Evan Wood
Journal:  Harm Reduct J       Date:  2009-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.